Research and Markets: Global Pancreatic Cancer Pipeline Review 2015

Research and Markets (http://www.researchandmarkets.com/research/t88pvm/pancreatic_cancer) has announced the addition of the "Pancreatic Cancer - Pipeline Review, 2015" report to their offering.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Pancreatic Cancer diagnostic tests pipeline products.

Scope

- Extensive coverage of the Pancreatic Cancer diagnostic tests under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Pancreatic Cancer diagnostic tests and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Products under Development

4 Pancreatic Cancer - Pipeline Products under Development by Companies

5 Pancreatic Cancer Companies and Product Overview

6 Pancreatic Cancer- Recent Developments

7 Appendix

Companies Mentioned

  • A&G Pharmaceutical, Inc.
  • Abcodia Ltd.
  • Acobiom
  • Andraka Technologies, LLC
  • Applied Proteomics, Inc.
  • Biouniversa s.r.l.
  • Cancer Research Technology Limited
  • Clovis Oncology, Inc.
  • CompanDX Ltd.
  • Courtagen Life Sciences, Inc.
  • CS-Keys, Inc.
  • Dartmouth College
  • Di.V.A.L Toscana srl
  • Exact Sciences Corporation
  • GeneFluidics Inc.
  • German Cancer Research Center
  • IV Diagnostics, Inc.
  • Matrix-Bio, Inc.
  • Mayo Clinic
  • MDNA Life Sciences, Inc.
  • Merrimack Pharmaceuticals, Inc.
  • National Cheng-Kung University Hospital
  • Neogenix Oncology, Inc.
  • Onconome, Inc.
  • OPKO Health, Inc.
  • Oxford Gene Technology Limited
  • PeriRx LLC
  • Precision Biologics, Inc.
  • Stanford University
  • The Johns Hopkins University
  • Thomas Jefferson University
  • US Biomarkers, Inc.
  • Viomics Inc.
  • Vitatex Inc.
  • VolitionRX Ltd.

For more information visit http://www.researchandmarkets.com/research/t88pvm/pancreatic_cancer

Contacts:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: In Vitro Diagnostics, Pancreatic Cancer

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.